top of page
Anchor 1

New study
open enrollment 


 Islets from stem cells
transplantation

 
Anchor 4
main

New studies with stem cell-derived islets  for patients with T1DM

OPEN ENROLLMENT

VX20-880-101 Study

​

  • for patients with T1DM and good kidney function

  • islets are infused in to the liver via a catheter

  • immunosupression medications are required

 

go to the study >

​

OPEN ENROLLMENT

VX24-880-102 Study (NEW study)

 

  • for patients with T1DM after kidney transplant

  • islets are infused in to the liver via a catheter

  • continue the same immunosupression medications  

 

go to the study >

​

ENROLLMENT
CLOSE

VX22-264-101 Study 

 

  • devices containing islets will be surgically implanted behind the muscles of the abdomen  

  • no immunosupression medication required

​

  • the study was terminated due to lack of effectiveness 

 

​

​

bottom of page